NasdaqGS:VSAT
NasdaqGS:VSATCommunications

Does Viasat’s Stock Rally Signal a Real Opportunity After Latest Global Partnership News?

Wondering if Viasat is a bargain or just riding the latest market buzz? You are not alone, as many investors are asking the same question after seeing dramatic moves in the stock price. Viasat’s stock has seen a tremendous year, soaring 219.6% year-to-date and 265.7% over the last 12 months. This comes even after a recent dip of 14.9% in the past week and 17.0% in the last month. The recent volatility follows major headlines, including new global partnerships and expansion deals that are...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

The Bull Case For SLM (SLM) Could Change Following Strong Q3 Earnings and Loan Growth Surge

SLM Corporation reported a US$132 million GAAP net income for Q3 2025, driven by a 6% rise in private education loan originations and a reduction in credit loss provisions following a major loan sale. This performance reflects SLM’s focus on disciplined capital management and operational strength, highlighted by improved loan portfolio quality and efficient risk controls. Next, we'll explore how SLM's increased education loan growth could influence its long-term investment narrative and...
NYSE:GEV
NYSE:GEVElectrical

The Bull Case For GE Vernova (GEV) Could Change Following First International Wind Repowering Deal in Taiwan

Taiwan Power Company recently announced an agreement with GE Vernova Inc. to supply 25 onshore wind repower upgrade kits in Taiwan, marking GE Vernova’s first such international contract beyond the United States and including a five-year operations and maintenance services package. This move highlights GE Vernova's expansion of its wind repowering expertise internationally, reinforcing its role in supporting decarbonization and energy infrastructure modernization in new markets. We'll...
NasdaqGM:NNOX
NasdaqGM:NNOXHealthcare

Nano-X Imaging (NNOX): Reassessing Valuation After 2026 Revenue Outlook and New Global Partnerships

Nano-X Imaging (NasdaqGM:NNOX) just drew attention with its upbeat 2026 revenue outlook, securing fresh commercial agreements across Europe and announcing a new reseller partnership that puts its FDA-cleared AI imaging tools into wider clinical use. See our latest analysis for Nano-X Imaging. Shares of Nano-X Imaging have been on a rollercoaster, rallying over 13% in a single day and 18% for the week following upbeat guidance and a string of strategic deals, including the Vaso Healthcare IT...
NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

Surgery Partners (SGRY): Assessing Valuation After Recent 27% Share Price Drop

Surgery Partners (SGRY) shares slipped after recent trading sessions, catching the attention of investors interested in the healthcare sector. With movement over the past month, some are now looking closely at the underlying business fundamentals to gauge the company’s outlook. See our latest analysis for Surgery Partners. Surgery Partners’ share price has struggled lately, with a steep 27% drop over the past month weighing on already negative momentum. Looking at the bigger picture, the...
NYSE:BAC
NYSE:BACBanks

New Product Launches and Analyst Optimism Could Be a Game Changer for Bank of America (BAC)

Over the past week, Bank of America unveiled a series of initiatives, including new fixed-income offerings, the launch of its 401k Pay retirement income solution, and expanded global sports partnerships, along with recent analyst reports highlighting increased optimism about the company's earnings potential. An interesting insight is that Bank of America’s focus on advanced technologies and workplace benefits directly aligns with the growing adoption of AI and revenue optimism among its...
NasdaqGS:NSSC
NasdaqGS:NSSCElectronic

Can Napco Security Technologies’ (NSSC) Push for Recurring Revenue Sustain Its Competitive Position?

At the International Security Conference & Exposition in New York, Napco Security Technologies unveiled its latest MVP ecosystem products, advanced StarLink communicators, and upgraded Gemini system components, aiming to expand recurring monthly revenue and hardware sales opportunities. A notable insight is management's disclosure that recurring communication revenue is nearing US$100 million annually, underscoring the company's success in building predictable and scalable revenue streams...
NYSE:LOB
NYSE:LOBBanks

A Look at Live Oak Bancshares’s Valuation Following New Dividend Declaration and Capital Return Focus

Live Oak Bancshares, Inc. just declared a new round of cash dividends for both common and preferred shareholders, a move that highlights the company’s ongoing effort to reward investors and maintain steady capital returns. See our latest analysis for Live Oak Bancshares. While Live Oak Bancshares’ announcement of fresh dividends underscores its focus on capital return, share price momentum has clearly faded in recent months. The company’s share price is now at $29.41, and the 1-year total...
NYSE:JHG
NYSE:JHGCapital Markets

Assessing Janus Henderson Group (NYSE:JHG): Is the Stock Undervalued After Recent Results?

Janus Henderson Group (JHG) recently reported annual revenue growth of 5% and a 2% increase in net income. This has prompted investors to consider how the current valuation reflects the company's latest financial progress. Over the past year, shares are down 2%. See our latest analysis for Janus Henderson Group. Janus Henderson Group’s share price has slipped about 2% over the past year, reflecting some fading momentum despite last year’s solid growth numbers and a relatively steady stream of...
NYSE:ESTC
NYSE:ESTCSoftware

Elastic (ESTC) Jumps After Revenue Beat and AI Upside Guidance—Is Its Platform Strategy Paying Off?

Elastic N.V. recently reported second-quarter revenue of US$423.48 million, exceeding analyst expectations and raising its full-year guidance to US$1.72 billion, fueled by robust demand for its AI and generative AI platform solutions. The company also launched new AI and observability features, including enhanced OpenTelemetry capabilities and support for PHP, further strengthening its positioning in the technology sector. We'll explore how Elastic’s improved revenue outlook, underpinned by...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

A Closer Look at Pegasystems (PEGA) Valuation Following Ongoing Share Price Weakness

Pegasystems (PEGA) shares have dipped about 3% in the latest session, continuing a stretch of weakness that has persisted over the past month. Investors appear to be keeping a close eye on both performance trends and sector sentiment. See our latest analysis for Pegasystems. Despite the recent dip, Pegasystems has delivered a solid 17.3% total shareholder return in the past year, with strong three-year gains of over 180% helping to offset more muted short-term price momentum. While the latest...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY): Is the Stock Undervalued After Recent Downtrend?

Best Buy (BBY) shares have slipped around 1% since yesterday, adding to a downward trend that has persisted over the past month. Investors are likely watching for clues about what could break this cycle. See our latest analysis for Best Buy. Best Buy’s 1-month share price return of -10.74% reflects softer momentum that has weighed on the stock all year, with recent headlines doing little to change the overall trend. Over the past year, total shareholder return landed at -10.35%, signaling...
NYSE:SYF
NYSE:SYFConsumer Finance

Toro Credit Card Collaboration Could Be a Game Changer for Synchrony Financial (SYF)

On November 20, 2025, The Toro Company announced the launch of its co-branded credit card program with Synchrony Financial, offering Toro, Exmark, Spartan, and Z Turf Equipment dealers access to digital account tools, advanced credit decisioning, and special financing options for customers. This collaboration highlights how Synchrony's PRISM technology and digital infrastructure are being leveraged to strengthen dealer support and drive customer loyalty through tailored financing...
NYSE:WFC
NYSE:WFCBanks

Wells Fargo (WFC): Exploring Valuation as Shares Dip 2% This Week

Wells Fargo (WFC) has seen its stock edge slightly lower over the past week, dipping around 2%. Investors may be eyeing recent broader market moves and looking for cues about what might come next for the banking giant. See our latest analysis for Wells Fargo. Despite this week's share price dip, Wells Fargo has shown solid momentum over the long haul with a 17.4% year-to-date share price return and an impressive 12.5% total shareholder return over the past twelve months. With performance like...
NYSE:XPEV
NYSE:XPEVAuto

Why XPeng (XPEV) Balances Record Deliveries With Cautious Profit Outlook and Heavy AI Investment

On November 17, 2025, XPeng reported record-breaking third-quarter results with revenue rising to CNY 20.38 billion and vehicle deliveries for the year-to-date reaching 355,209, while also narrowing its net loss compared to the previous year. The company’s cautious fourth-quarter guidance and ongoing investments in AI-driven projects and robotics highlight both strong operational momentum and growing concerns about near-term profitability. Let’s explore how XPeng’s record deliveries and...
NYSE:CURB
NYSE:CURBRetail REITs

Curbline Properties (CURB): Evaluating Valuation After Citigroup’s Buy Upgrade and Analyst Optimism

Citigroup’s recent upgrade of Curbline Properties (CURB) to a Buy rating has drawn attention to the company’s above-average earnings growth, lean leasing costs, and a tenant base that keeps risk in check. This shift comes as analysts show increased conviction in Curbline’s outlook. They point to the company’s evolving growth strategy as a key focus for investors. See our latest analysis for Curbline Properties. Momentum around Curbline Properties has been building since its recent debt...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Is Up 15.4% After Raising Guidance on Strong MRD Test Momentum Has the Bull Case Changed?

In the past week, Adaptive Biotechnologies reported third quarter results that surpassed market expectations, citing robust performance in its minimal residual disease (MRD) testing business led by the clonoSEQ test and supported by increased average selling prices. An important insight from this update is management’s decision to raise full-year guidance, reflecting growing clinical adoption and sustained momentum for MRD testing across hematological cancers. To understand the impact of...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD): Assessing Valuation After Dividend Hike and Portfolio Moves

Royal Gold (RGLD) just announced a 6% increase to its annual dividend for 2026, raising the payout from $1.80 to $1.90 per share. This move highlights management’s confidence in future cash flows and commitment to rewarding shareholders. See our latest analysis for Royal Gold. The recent dividend boost comes on the back of several portfolio moves, including strategic acquisitions and exiting non-core holdings. Building on this momentum, Royal Gold’s share price is up 36.6% year-to-date, and...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Can Crocs’ (CROX) Leadership Shift Revitalize the HEYDUDE Brand’s Recovery Strategy?

On November 17, 2025, Crocs, Inc. promoted Rupert Campbell to Executive Vice President and President of its HEYDUDE brand, adding him to the executive leadership team reporting directly to the CEO. This appointment brings to Crocs a leader with global footwear expertise, notably from his tenure as President of adidas North America, during a period when the HEYDUDE brand has faced recent sales challenges. We will examine how Campbell’s addition to the executive team could influence Crocs'...
NYSE:PIPR
NYSE:PIPRCapital Markets

Did Piper Sandler's (PIPR) Private Markets Push with Former Forge Global Team Shift Its Investment Narrative?

Piper Sandler Companies recently announced the launch of a private markets trading initiative, hiring Patrick Gordon, Kyle Mooney, and David Ilishah as managing directors, all joining from Forge Global to lead this effort. This move represents a significant push into trading equity shares of private companies, backed by nearly two decades of private securities experience from the new team. We’ll examine how Piper Sandler’s expansion into private markets could influence its overall investment...
NasdaqGS:FBNC
NasdaqGS:FBNCBanks

Will First Bancorp's (FBNC) Risk Transition Shape Its Regulatory Advantage in the Years Ahead?

First Bank recently announced that Bridget Welborn joined in October 2025 as Chief Risk Officer and Head of Legal, bringing more than 15 years of experience in legal, risk, privacy, and regulatory compliance, including prior leadership roles at State Employees' Credit Union. This executive hire comes as First Bank prepares for transitions in its risk leadership, with outgoing EVP Peter Seitz assisting during the changeover before his retirement in January 2026. We’ll explore how Welborn’s...
NYSE:TOL
NYSE:TOLConsumer Durables

Toll Brothers (TOL): Exploring Valuation as Shares Slip Within a Broader Multi-Month Decline

Toll Brothers (TOL) shares dipped slightly this week, giving investors new data to digest as the stock continues to move within a broader three-month decline. Despite this, the company’s long-term returns remain far stronger. See our latest analysis for Toll Brothers. After a stellar multi-year run, Toll Brothers’ recent share price slip hints at shifting momentum, with the 1-year total shareholder return now at -16.4%. However, long-term holders have still seen a remarkable 180% total return...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Why Astrana Health (ASTH) Cut Guidance Despite Strong Revenue Growth After Prospect Integration

Astrana Health reported fiscal Q3 2025 results in the past, showing significant year-over-year revenue growth due to Prospect Health integration, but also lowered its full-year revenue and Adjusted EBITDA guidance amid anticipated Medicaid and exchange business headwinds. The reduction in guidance despite strong top-line momentum underscores the ongoing uncertainty facing value-based care operators exposed to government-backed health programs. We'll explore how Astrana Health's cautious...
NYSE:BAH
NYSE:BAHProfessional Services

Is There Opportunity in Booz Allen Hamilton After Recent 20% Share Price Drop?

Wondering whether Booz Allen Hamilton Holding might be undervalued or present a hidden opportunity? You are not alone, and this is exactly what we will unpack together. Shares have seen a rocky ride recently, dropping 5.1% over the past week and tumbling 20.6% in the last month. The year-to-date slide now stands at a substantial 37.6%, and the full year decline is 45.5%. Several headline developments have given investors pause, such as ongoing shifts in government contracting budgets and...